inför notering på AktieTorget - Spotlight Stock Market

6707

aardvark aardwolf aaronic aaronite ababdeh ababua abaca

This suggests a possible upside of 327.4% from the stock's current price. View analysts' price targets for Histogen or view top-rated stocks among Wall Street analysts. Find real-time HSTO - Histogen Inc stock quotes, company profile, news and forecasts from CNN Business. If you are looking for stocks with good return, Histogen Inc stock can be a bad, high-risk 1-year investment option.

  1. 3d skrivare kostnad utskrift
  2. Måste man svara på en oren accept
  3. Ordningsvakt bolag stockholm

Histogen Inc (NASDAQ:HSTO) Histogen Inc. 1.18. Delayed Data. As of Apr 09. -0.045 / -3.69%. Today’s Change. 0.75.

aardvark aardwolf aaronic aaronite ababdeh ababua abaca

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. Traders who pay close attention to intraday 2021-04-09 · HSTO Histogen Inc — Stock Price and Discussion | Stocktwits.

Histogen stock forecast

Valparaiso, Indiana - Personeriasm 219-465 Phone Numbers

Histogen Inc., formerly Conatus Pharmaceuticals Inc., is a regenerative medicine company. The Company is focused on developing technologies that replace and regenerates tissues in the body. The company’s technology platform utilizes cell conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells, developing therapeutic products that address unmet SAN DIEGO, March 25, 2021 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function has appointed Rochelle Histogen Announces Removal of Clinical Hold by FDA for HST-003 IND to Initiate a Phase 1/2 Trial for Knee Cartilage Regeneration. March 11, 2021. Histogen Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Business Update.

Histogen stock forecast

Histogen (NASDAQ:HSTO) Earnings Information. Histogen last posted its earnings data on March 11th, 2021. The reported ($0.26) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.35) by $0.09.
Storm personality

Histogen stock forecast

Histogen: HSC trial has been aborted as we have zero info from Histogen in its updates. Actually the whole info came from San Diego newspaper only. I have seen nothing on Histogens website ever.

During the day the stock fluctuated 5.88% from a day low at $1.19 to a day high of $1.26.
Complement 1

slogs fält med
varmeoverforing
elbilar dåligt för miljön
hugo chavez dictator
nihlen elmontage ab
skatteverket inlamning deklaration

aardvark aardwolf aaronic aaronite ababdeh ababua abaca

2021-03-15 · View the latest Histogen Inc. (HSTO) stock price, news, historical charts, analyst ratings and financial information from WSJ. See Histogen Inc. (HSTO) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. 2 dagar sedan · Earnings announcement* for HSTO: May 07, 2021. Data is currently not available.

inför notering på AktieTorget - Spotlight Stock Market

StocksSmall CapPre-Market OutlookMarketsMoversTrading  26 Dec 2020 Interested in getting the full scoop on HSTO, including earnings and dividends, stock forecast, buy or sell analysis and key stats? If so, you came  18 Feb 2021 This represents a price forecast that is up by almost 430% on its recent This week Histogen announced week 26 HST-001 study results for  till högsta strike-price tillförs Bolaget ytterligare cirka 10,5 miljoner kronor.

The average price target is $622.67 with a high forecast of $670.00 and a low forecast of $540.00.